A detailed history of Advisor Group Holdings, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 205 shares of TARS stock, worth $9,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205
Previous 222 7.66%
Holding current value
$9,563
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.54 - $34.6 $366 - $588
-17 Reduced 7.66%
205 $6,000
Q1 2024

May 10, 2024

BUY
$19.61 - $39.22 $823 - $1,647
42 Added 23.33%
222 $8,000
Q3 2023

Nov 13, 2023

SELL
$14.75 - $24.62 $870 - $1,452
-59 Reduced 24.69%
180 $3,000
Q2 2023

Aug 10, 2023

SELL
$11.57 - $19.63 $3,818 - $6,477
-330 Reduced 58.0%
239 $4,000
Q4 2022

Feb 10, 2023

BUY
$14.12 - $18.72 $5,210 - $6,907
369 Added 184.5%
569 $8,000
Q3 2021

Nov 05, 2021

BUY
$21.45 - $29.22 $4,290 - $5,844
200 New
200 $4,000

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.24B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.